Form 4: Puma Biotechnology Director Alessandra Cesano Granted 27,000 Restricted Stock Units

Puma Biotechnology, Inc. Director Alessandra Cesano was granted 27,000 shares of common stock in the form of Restricted Stock Units on June 11, 2025, increasing her total beneficial ownership to 81,000 shares.

Summary

• Alessandra Cesano, a Director of Puma Biotechnology, Inc. (PBYI), acquired 27,000 shares of Common Stock on June 11, 2025.
• The acquisition was in the form of Restricted Stock Units (RSUs) granted at a price of $0.
• These RSUs are scheduled to vest in full on the earlier of the one-year anniversary of the grant date or the date of the annual shareholder meeting following the grant date, subject to Ms. Cesano's continued service with the Issuer.
• Following this transaction, Alessandra Cesano's total beneficial ownership of Puma Biotechnology, Inc. Common Stock stands at 81,000 shares.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is generally viewed positively as it aligns the director's financial interests with the long-term performance of the company and shareholder value.

Positives

• The grant of 27,000 Restricted Stock Units to Director Alessandra Cesano at a price of $0 indicates a non-cash compensation component, aligning her interests with long-term shareholder value.
• The increase in beneficial ownership to 81,000 shares demonstrates continued commitment from a key director.

Future Outlook

The 27,000 Restricted Stock Units granted are set to vest in full on the earlier of the one-year anniversary of the grant date (June 11, 2026) or the date of the annual shareholder meeting following the grant date, contingent on the reporting person's continued service.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information on broader industry trends or competitive landscape, but rather reflects standard compensation practices for directors within the biotechnology sector, often involving equity grants to align interests.

Related Party Transactions

• The grant of 27,000 Restricted Stock Units to Alessandra Cesano, a Director of Puma Biotechnology, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant of equity to a director aligns their interests with long-term shareholder value, potentially encouraging decisions that benefit the company's stock performance.

Next Steps

• The vesting of the 27,000 Restricted Stock Units will occur on the earlier of June 11, 2026, or the date of the annual shareholder meeting following the grant date, subject to continued service.

Key Dates

Recommendation

Keywords

Puma Biotechnology, PBYI, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Stock Grant, Alessandra Cesano